BOBBY LE: Open Payments
NPI 1063113843 · LAKEWAY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 19 payments from 8 companies in 2025. Trend: 2023 $100 · 2024 $430 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $167 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Dexcom, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: SHINGRIX, Wegovy, Rybelsus, JARDIANCE, AIRSUPRA, MOUNJARO, Ozempic, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
